Targeting PIK3CA Mutations in Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Targeting PIK3CA Mutations in Breast Cancer | Targeted Oncolog…
Aug 12, 2023
targetedonc.com
31K views · 166 reactions | PIK3CA mutations are present in...
1:32
31K views · 166 reactions | PIK3CA mutations are present in...
31K views1 month ago
FacebookNovartis Cancer
PIK3CA is the most commonly mutated gene in ~40% of patients with HR+/HER2- breast cancer. Learn more about the PIK3CA mutation, how it may affect your cancer care and questions to ask your doctor about testing for mutations. #ASCO21 https://bddy.me/2T20ydO | Novartis Cancer | Facebook
0:11
PIK3CA is the most commonly mutated gene in ~40% of patients …
2K views1 month ago
FacebookNovartis Cancer
"The PIK3CA mutation test is used to determine eligibility for a kinase inhibitor treatment in a subset of patients with breast cancer," Dr. Katherine Geiersbach says. That subset is postmenopausal women or men who have hormone receptor-positive breast cancer that has progressed despite endocrine-based therapy. The kinase inhibitor, known as alpelisid, targets the PIK3CA mutation. Learn more in this “Test in Focus.” https://bit.ly/3AkowUJ | Mayo Clinic Laboratories
0:44
"The PIK3CA mutation test is used to determine eligibility for a kinas…
371 viewsNov 16, 2022
FacebookMayo Clinic Laboratories
Role of PI3K/AKT/PTEN Pathway in HR /HER2- Advanced Breast Cancer | OncLive
Role of PI3K/AKT/PTEN Pathway in HR /HER2- Advanced Breast Canc…
Oct 21, 2024
onclive.com
BYLieve: CDK4/6 Treatment Duration and Alpelisib Benefit in HR /HER2-/PIK3CA-Mutated Advanced Breast Cancer | OncLive
BYLieve: CDK4/6 Treatment Duration and Alpelisib Benefit in H…
Jul 9, 2021
onclive.com
Case Presentation 1: PIK3CA Mutation With ESR1 Mutations | OncLive
Case Presentation 1: PIK3CA Mutation With ESR1 Mutations | O…
Jul 1, 2024
onclive.com
Roche Unveils Cobas PIK3CA Mutation Test For Breast Cancer P…
Dec 14, 2020
nasdaq.com
NCCN Guidelines Update for ER+ Breast Cancer: CDK4/6 and PIK3C…
9.4K viewsSep 13, 2019
vumedi.com
1:30
In breast cancer, over 40% of HR cases have PIK3CA mutations, dri…
359.8K viewsNov 13, 2024
FacebookGenentech
Molecular Tumor Board: 64 year-old female with recurrent breast canc…
Oct 20, 2023
labcorp.com
SOLAR-1 and CBYL719X2101: Alpelisib Fulvestrant in HR /HER2 …
Jul 9, 2021
onclive.com
1:47
Oestrogen-receptor positive (ER ) breast cancers account for over 7…
11.1K viewsJul 1, 2020
FacebookBreast Cancer Trials
Dr Rugo on the FDA Approval of Inavolisib Plus Palbociclib and Ful…
Oct 11, 2024
onclive.com
7:08
Pi3k Pathway
68.4K viewsJun 15, 2015
YouTubeShomu's Biology
0:46
PIK3CA Mutations in Breast Cancer Explained
1.4K views2 months ago
YouTubeYerbba – Breast Cancer
7:27
Breast Cancer Mutations: BRCA1, BRCA2, CHEK2, TP53, ESR1, PIK3…
2K views5 months ago
YouTubeYerbba – Breast Cancer
1:59
Dr. Hurvitz on Patient Outcomes and PIK3CA Mutations
1.5K viewsJul 18, 2014
YouTubeTargeted Oncology
12:55
Molecular Tumor Board Series - Breast Cancer with ESR1 and PIK…
818 viewsNov 28, 2022
YouTubeCirculogene
1:27
Deciphering the Role of PI3K Mutations in HER2+ Breast Cancer
5.7K viewsJul 26, 2017
YouTubeASCOcancer
46:29
Oncogene additivity in the PI3K pathway in cancer
1.4K viewsDec 1, 2020
YouTubeLabroots
15:46
Targeting PIK3CA Mutations in HR+/HER2- Breast Cancer: New In…
1 views2 months ago
YouTubeReachMD
26:17
The PI3K / AKT / mTOR Pathway and Cancer Part 5
4.1K viewsMay 1, 2015
YouTubeElliot Nicholson
8:28
pi3k/akt/mtor pathway
105.8K viewsJun 15, 2015
YouTubeShomu's Biology
1:00:52
Understanding Cancer Lecture 8 PI3K/AKT/mTOR pathway normal …
82 viewsSep 18, 2023
YouTubeHafsa Waseela
4:20
PIK3CA Mutations in HER2-Positive Breast Cancer
3.4K viewsFeb 10, 2014
YouTubeOncLive
1:09
ASCO 2025: Exploring Mutation Landscapes in Hormone Positive …
3 views1 month ago
YouTubeInnovative Oncology News
4:44
The PI3K/AKT signalling pathway
516.8K viewsFeb 22, 2010
YouTubeOnkoview
How PI3K and AKT inhibitors are changing breast cancer treatment…
8 months ago
linkedin.com
Targeting the PI3K Pathway in HR /HER2- MBC | OncLive
Nov 15, 2021
onclive.com
See more videos
Static thumbnail place holder